← FDA Drug Approvals (Drugs@FDA)

NEXLETOL

NDA · New Drug Application · Sponsor: ESPERION THERAPS INC · Approved 2020-02-21

Drug application

FDA Application #

NDA211616

Application type

New Drug Application

Brand name

NEXLETOL

Generic name

BEMPEDOIC ACID

Active ingredients

BEMPEDOIC ACID

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ESPERION THERAPS INC

Manufacturer

Esperion Therapeutics, Inc.

First approval

2020-02-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown